Antti Rannikko co-leads the prostate cancer research group in Helsinki Urological Cancer Centre.
Tuomas Mirtti co-leads the prostate cancer research group in Helsinki Urological Cancer Centre.
Petrus Järvinen leads the kidney cancer research group in Helsinki Urological Cancer Centre.
Jukka Sairanen co-leads the bladder cancer research group in Helsinki Urological Cancer Centre.
Riikka Järvinen co-leads the bladder cancer research group in Helsinki Urological Cancer Centre.
Hanna Vasarainen co-leads the testicular cancer and penile cancer research groups in Helsinki Urological Cancer Centre.
Otto Hemminki co-leads the testicular cancer research group in Helsinki Urological Cancer Centre.
Tuomas Jalanko co-leads the penile cancer research group in Helsinki Urological Cancer Centre.
Docent, Prostatic Proteases group leader, Faculty of Medicine, University of Helsinki, Finland
We study proteases as novel prostate cancer markers and drug targets. This involves development of novel patient-derived tissue and cell models, addressing also the role of tumor microenvironment. Apart from the functional studies, we develop protease inhibitors as drug leads and perform different marker studies, including those addressing cancer specific glycoforms of glycoprotein markers. Projects are underpinned by a wide international collaborative network.
PhD Kevin Sandeman defended his doctoral dissertation on the topic ‘